We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HOPKINTON, Mass., June 8 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSINASDAQ:andNASDAQ:ALSE) today announced that its proposed name change to Alseres Pharmaceuticals, Inc...
HOPKINTON, Mass., June 5 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that the Company will provide a corporate and program update following the formal...
Key Thought Leaders in the Area of Spinal Cord Injury Research to Advise on Cethrin(R) Development Program HOPKINTON, Mass., May 29 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc...
HOPKINTON, Mass., May 9 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that they will host a conference call on Wednesday, May 16th, 2007 at 10:00am EDT to...
HOPKINTON, Mass., May 3 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that it entered into an amendment to the Convertible Promissory Note Purchase Agreement...
HOPKINTON, Mass., May 1 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice, Executive Vice President and Chief Financial Officer of Boston Life...
HOPKINTON, Mass., April 17 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) announces, in accordance with NASDAQ Marketplace Rule 4350, as amended, it granted inducement stock...
Company Announces Extension of Phase I/IIa Trial to 9 mg Dosage Level HOPKINTON, Mass., April 16 /PRNewswire-FirstCall/ -- Boston Life Sciences (NASDAQ:BLSI) announced today that clinical data...
Veteran Pharmaceutical Executive Will Lead BLSI's Business Development Efforts HOPKINTON, Mass., April 16 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc., (NASDAQ:BLSI), a biopharmaceutical...
HOPKINTON, Mass., April 12 /PRNewswire-FirstCall/ -- Boston Life Sciences (NASDAQ:BLSI), a biopharmaceutical company focused on the research and clinical development of diagnostic and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions